Bupropion treatment for cocaine abuse and adult attention-deficit/hyperactivity disorder

Journal of Addictive Diseases
Frances R LevinEdward Nunes

Abstract

There are few published studies assessing the efficacy of pharmacologic treatments for attention-deficit hyperactivity disorder (ADHD) among substance abusers seeking treatment. Eleven patients who met DSM-IV diagnostic criteria for cocaine dependence and adult ADHD were entered into a 12-week single-blind trial of divided daily doses of bupropion (BPR). All patients received weekly individual standardized relapse prevention therapy. Treatment compliance and retention were good. Patients reported significant reductions in attention difficulties, hyperactivity and impulsivity. Self-reported cocaine use, cocaine craving, and cocaine positive toxicologies, also decreased significantly. In a previously published trial, 12 patients who met similar diagnostic criteria for adult ADHD and cocaine dependence were entered into a 12-week trial of divided daily doses of sustained-release methylphenidate (MPH). Improvements observed on BPR were similar to, and did not differ from those previously observed with MPH. These preliminary data suggest that BPR may be as effective as sustained-release MPH, when combined with relapse prevention therapy, for cocaine abusers with adult ADHD. However, a future study directly comparing BPR to MPH in a ...Continue Reading

References

Jun 1, 1979·Archives of General Psychiatry·G WeissA Wener
Jun 1, 1991·The Australian and New Zealand Journal of Psychiatry·F Levy
Jan 1, 1991·Archives of General Psychiatry·A MargolinT Kosten
Jan 1, 1991·Archives of General Psychiatry·B J RounsavilleF Gawin
Jan 1, 1991·Archives of General Psychiatry·S MannuzzaK A Addalli
Aug 1, 1990·The American Journal of Psychiatry·P H Wender, F W Reimherr
Jun 1, 1990·The American Journal of Psychiatry·N D VolkowD Christman
Nov 1, 1985·The American Journal of Psychiatry·E J Khantzian
Jan 1, 1980·The Journal of Nervous and Mental Disease·A T McLellanC P O'Brien
Aug 1, 1995·Journal of Clinical Psychopharmacology·T E WilensJ Prince
May 1, 1995·Journal of the American Academy of Child and Adolescent Psychiatry·L L BarrickmanE Schumacher
Mar 1, 1994·Archives of General Psychiatry·K M CarrollF H Gawin
Mar 1, 1993·Journal of Studies on Alcohol·K M CarrollK J Bryant
Apr 1, 1996·Current Opinion in Neurobiology·R A Wise
Oct 1, 1996·Journal of the American Academy of Child and Adolescent Psychiatry·C K ConnersJ Ascher
Dec 16, 1998·Journal of the American Academy of Child and Adolescent Psychiatry·P D RiggsL C Pottle

❮ Previous
Next ❯

Citations

Oct 30, 2012·Neuropsychiatry·Timothy E Wilens, Nicholas R Morrison
Mar 4, 2008·Primary Care Companion to the Journal of Clinical Psychiatry·Chaya G BhuvaneswarTheodore A Stern
Nov 3, 2005·Journal of Child and Adolescent Psychopharmacology·James G Waxmonsky, Timothy E Wilens
Nov 3, 2005·Journal of Child and Adolescent Psychopharmacology·Ramon SolhkhahJoseph Biederman
Feb 25, 2009·Advances in Therapy·Wim VerbeeckGeertruida E Bekkering
Oct 1, 2008·Postgraduate Medicine·Larry Culpepper, Gregory Mattingly
Oct 1, 2011·Expert Review of Neurotherapeutics·Timothy E WilensJefferson Prince
Dec 24, 2015·Expert Review of Neurotherapeutics·Massimiliano BuoliWiepke Cahn
Apr 21, 2006·Expert Review of Neurotherapeutics·Oscar G Bukstein
Nov 12, 2005·Substance Use & Misuse·Aparna S Kalbag, Frances R Levin
Jul 16, 2013·Substance Use & Misuse·Brian C KellyJeffrey T Parsons
Apr 9, 2008·Pharmacology & Therapeutics·Margaret I Davis
Apr 12, 2008·Drug and Alcohol Dependence·Timothy E WilensUNKNOWN Atomoxetine ADHD/SUD Study Group
Jul 10, 2003·The American Journal on Addictions·Jill Williams, Douglas M Ziedonis
Mar 18, 2011·British Journal of Pharmacology·Catharine A Winstanley
Dec 12, 2012·British Journal of Clinical Pharmacology·José Pérez de los CobosJoan Trujols
Aug 2, 2007·Primary Care·Sreenivas Katragadda, Howard Schubiner
Oct 16, 2003·Pediatric Clinics of North America·Donald E GreydanusMarsha D Rappley
Nov 14, 2014·Journal of Dual Diagnosis·Kristine Fiksdal AbelEgil W Martinsen
Mar 6, 2013·Journal of Psychoactive Drugs·Shaul Lev-Ran
Dec 17, 2015·Journal of Correctional Health Care : the Official Journal of the National Commission on Correctional Health Care·Duncan A ScottGunter W Lorberg
Feb 7, 2015·Journal of Attention Disorders·Michelle J ZasoKevin M Antshel
Apr 24, 2007·Neurotoxicity Research·Neil E Paterson, Athina Markou
Mar 23, 2010·International Clinical Psychopharmacology·Giorgio Racagni, Maurizio Popoli
Nov 12, 2005·Journal of Clinical Psychopharmacology·Pinhas N DannonMoshe Kotler
Aug 24, 2017·BMC Psychiatry·Martin A KatzmanLarry J Klassen
Dec 14, 2011·The Cochrane Database of Systematic Reviews·Pier Paolo PaniLaura Amato
May 4, 2017·Annals of General Psychiatry·Sam-Wook ChoiHyunChul Youn
Jul 1, 2006·Revista brasileira de psiquiatria : orgão oficial da Associação Brasileira de Psiquiatria, Asociación Psiquiátrica de la América Latina·Marcos ZaleskiUNKNOWN Brazilian Association of Studies on Alcohol and Other Drugs

❮ Previous
Next ❯

Related Concepts

Related Feeds

Attention Disorders

Attention is involved in all cognitive activities, and attention disorders are reported in patients with various neurological diseases. Here are the latest discoveries pertaining to attention disorders.